Heather Agnew, Ph.D.
Advisor & Technology Co-Inventor, Indi Molecular

Dr. Agnew is the co-inventor of PCC technology, the platform Indi Molecular used to create its oncology therapeutics. She previously served as Indi Molecular’s Vice President R&D Operations. Dr. Agnew joined Integrated Diagnostics (the parent company of Indi Molecular) in 2010. She was responsible for leading the development of the PCC platform to create targeted peptide ligands for therapeutics, imaging, and biological tools. She also held an adjunct faculty appointment in the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA.

Dr. Agnew holds a B.S. in chemistry and a B.S. in biochemistry and molecular biology from Penn State University, an M.Phil. in chemistry from University of Cambridge, and a Ph.D. in chemistry from Caltech, where she studied in the laboratory of Professor Jim Heath.

Her awards include the Gates Cambridge Scholarship (2003), NSF Graduate Research Fellowship (2003), and the $30,000 Lemelson-MIT Caltech Student Prize (2010).